CSIMarket
 


Kyto Technology And Life Science Inc   (KBPH)
Other Ticker:  
 
 

KBPH's Net Income Growth by Quarter and Year

Kyto Technology And Life Science Inc 's Net Income results by quarter and year




KBPH Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter March - 0.15 -0.36 -0.07
III Quarter December 0.32 0.00 -0.09 -0.06
II Quarter September 1.00 0.32 -0.12 -0.06
I Quarter June -0.33 -0.04 -0.20 -0.04
FY   0.99 0.43 -0.77 -0.23



KBPH Net Income third quarter 2022 Y/Y Growth Comment
Kyto Technology And Life Science Inc in the third quarter 2022 achieved Net Income of $ 0.32 millions compare to net loss recorded in same quarter a year ago.

According to the results reported in the third quarter 2022, Kyto Technology And Life Science Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Kyto Technology And Life Science Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter 2022.




KBPH Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter March - - - -
III Quarter December - - - -
II Quarter September 212.5 % - - -
I Quarter June - - - -
FY   - - - -

Financial Statements
Kyto Technology And Life Science Inc 's third quarter 2022 Net Income $ 0.32 millions KBPH's Income Statement
Kyto Technology And Life Science Inc 's third quarter 2021 Net Income $ 0.00 millions Quarterly KBPH's Income Statement
New: More KBPH's historic Net Income Growth >>


KBPH Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter March - - - -
III Quarter December -67.99 % - - -
II Quarter September - - - -
I Quarter June - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Kyto Technology And Life Science Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
-67.86 % -67.86 % -67.86 %
(Dec 31 2021)  


KBPH's III. Quarter Q/Q Net Income Comment
In the III. Quarter 2022 Kyto Technology And Life Science Inc disclosed fall in Net Income from the previous quarter by -67.99% to $ 0.32 millions, from $ 1.00 millions released a quarter before.

Within Major Pharmaceutical Preparations industry 21 other companies have achieved higher Net Income quarter on quarter growth. While Kyto Technology And Life Science Inc 's Net Income growth quarter on quarter, overall rank is 1362.


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #22
Healthcare Sector #100
Overall #1362
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #22
Healthcare Sector #100
Overall #1362
Net Income Q/Q Growth Statistics
High Average Low
-67.86 % -67.86 % -67.86 %
(Dec 31 2021)  


KBPH's III. Quarter Q/Q Net Income Comment
In the III. Quarter 2022 Kyto Technology And Life Science Inc reported fall in Net Income from the previous quarter by -67.99% to $ 0.32 millions, from $ 1.00 millions declared in the previous reporting period.

Within Major Pharmaceutical Preparations industry 21 other companies have achieved higher Net Income quarter on quarter growth. While Kyto Technology And Life Science Inc 's Net Income growth quarter on quarter, overall rank is 1362.


Kyto Technology And Life Science Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
Cumulative Net Income 12 Months Ending $ 1.13 $ 0.81 $ 0.13 $ 0.43 $ -0.09
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) 40.01 % 513.08 % -69.06 % - -
Seq. Net Income Growth (TTM) Overall Ranking # 464 # 34 # 2307 # 0 # 0




Cumulative Net Income growth Comment
In the Dec 31 2021 period, Kyto Technology And Life Science Inc had cumulative twelve months Net Income of $ 1 millions compare to net loss of $ 0 millions a year ago.
It is progress, although with caution, recording less then standard 40.01 % Net Income increase, from $0.81 millions from the twelve months ending in the quarter before Natala Romano continued.

Kyto Technology And Life Science Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
513.08 %
161.35 %
-69.06 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 37
S&P 500 # 464
Cumulative Net Income growth Comment
In the Dec 31 2021 period, Kyto Technology And Life Science Inc had cumulative twelve months Net Income of $ 1 millions compare to net loss of $ 0 millions a year ago.
It is recovery, although with caution, recording below average 40.01 % Net Income advance, from $0.81 millions from the period from Sep 30 2021 to Dec 31 2020.

Kyto Technology And Life Science Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
513.08 %
161.35 %
-69.06 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 37
S&P 500 # 464




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
KBPH's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for KBPH's Competitors
Net Income Growth for Kyto Technology And Life Science Inc 's Suppliers
Net Income Growth for KBPH's Customers

You may also want to know
KBPH's Annual Growth Rates KBPH's Profitability Ratios KBPH's Asset Turnover Ratio KBPH's Dividend Growth
KBPH's Roe KBPH's Valuation Ratios KBPH's Financial Strength Ratios KBPH's Dividend Payout Ratio
KBPH's Roa KBPH's Inventory Turnover Ratio KBPH's Growth Rates KBPH's Dividend Comparisons



Companies with similar Net Income fall for the quarter ending Dec 31 2021 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2021
Medpace Holdings Inc -1.64%$ -1.636 millions
Charles River Laboratories International inc -3.03%$ -3.026 millions
3m Company-3.60%$ -3.597 millions
Idexx Laboratories Inc-6.97%$ -6.966 millions
Abbott Laboratories-8.00%$ -8.002 millions
Dr Reddy s Laboratories Limited-8.88%$ -8.880 millions
Horizon Therapeutics Public Limited Company-9.12%$ -9.118 millions
Surgery Partners Inc -10.44%$ -10.438 millions
Lemaitre Vascular Inc -12.20%$ -12.200 millions
Vanda Pharmaceuticals Inc -13.58%$ -13.578 millions
Fresenius Medical Care Ag-15.10%$ -15.100 millions
Integrated Biopharma Inc-15.77%$ -15.768 millions
Owens and Minor inc-17.28%$ -17.276 millions
Syneos Health Inc -17.33%$ -17.333 millions
Eli Lilly And Company-18.46%$ -18.457 millions
Catalyst Pharmaceuticals Inc -18.61%$ -18.607 millions
Viemed Healthcare Inc -19.40%$ -19.404 millions
Xoma Corporation-19.42%$ -19.421 millions
Halozyme Therapeutics Inc -20.10%$ -20.100 millions
Gsk Plc-20.23%$ -20.225 millions
Envista Holdings Corporation-20.85%$ -20.849 millions
Ufp Technologies Inc -22.84%$ -22.843 millions
Tenet Healthcare Corp-23.26%$ -23.260 millions
Hologic Inc-23.72%$ -23.716 millions
Universal Health Services Inc -23.99%$ -23.989 millions
Amedisys Inc -25.38%$ -25.384 millions
Abiomed Inc -26.05%$ -26.049 millions
Electromed Inc -30.37%$ -30.366 millions
Chemed Corporation-30.63%$ -30.633 millions
Quest Diagnostics Inc-32.18%$ -32.184 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com